相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma
Qiuji Wu et al.
ORAL ONCOLOGY (2020)
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma
Anne W. M. Lee et al.
CANCER (2020)
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
Sik-Kwan Chan et al.
FRONTIERS IN ONCOLOGY (2020)
Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis
Juan Che et al.
BMC CANCER (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
Qi Yang et al.
EUROPEAN JOURNAL OF CANCER (2019)
Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
Jiawei Lv et al.
NATURE COMMUNICATIONS (2019)
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
Liang Peng et al.
RADIATION ONCOLOGY (2019)
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
R. L. Hong et al.
ANNALS OF ONCOLOGY (2018)
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
M. Frikha et al.
ANNALS OF ONCOLOGY (2018)
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Su-Mei Cao et al.
EUROPEAN JOURNAL OF CANCER (2017)
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen et al.
EUROPEAN JOURNAL OF CANCER (2017)
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis
Rui You et al.
THERANOSTICS (2017)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
Optimize the cycle of neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A propensity score matching analysis
Hao Peng et al.
ORAL ONCOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Ranking treatments in frequentist network meta-analysis works without resampling methods
Gerta Ruecker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2015)
Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
Terence Tan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
Anne W. M. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard et al.
LANCET ONCOLOGY (2015)
Preliminary Results of Trial NPC-0501 Evaluating the Therapeutic Gain by Changing From Concurrent-Adjuvant to Induction-Concurrent Chemoradiotherapy, Changing From Fluorouracil to Capecitabine, and Changing From Conventional to Accelerated Radiotherapy Fractionation in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Anne W. M. Lee et al.
CANCER (2015)
A primer on network meta-analysis with emphasis on mental health
Dimitris Mavridis et al.
EVIDENCE-BASED MENTAL HEALTH (2015)
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
G. Fountzilas et al.
ANNALS OF ONCOLOGY (2012)
Network meta-analysis, electrical networks and graph theory
Gerta Ruecker
RESEARCH SYNTHESIS METHODS (2012)
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer
Pierre Blanchard et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
Edwin P. Hui et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)